| Eltrombopag added to standard immunosuppression for aplastic anemia DM Townsley, P Scheinberg, T Winkler, R Desmond, B Dumitriu, O Rios, ... New England Journal of Medicine 376 (16), 1540-1550, 2017 | 504 | 2017 |
| A study of primary caesarean section in multipara E Desai, H Leuva, B Leuva, M Kanani Int J Reprod Contracept Obstet Gynecol 2 (3), 320-4, 2013 | 55 | 2013 |
| Eltrombopag added to standard immunosuppression for aplastic anemia accelerates count recovery and increases response rates DM Townsley, B Dumitriu, P Scheinberg, R Desmond, X Feng, O Rios, ... Blood 126 (23), LBA-2, 2015 | 28 | 2015 |
| Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia EM Groarke, BA Patel, R Shalhoub, F Gutierrez-Rodrigues, P Desai, ... Leukemia 36 (9), 2328-2337, 2022 | 26 | 2022 |
| Adrenocortical cancer: a molecularly complex disease where surgery matters EC Payabyab, S Balasubramaniam, M Edgerly, M Velarde, MJ Merino, ... Clinical Cancer Research 22 (20), 4989-5000, 2016 | 21 | 2016 |
| A novel approach to assess real-world efficacy of cancer therapy in metastatic prostate cancer. Analysis of national data on Veterans treated with abiraterone and enzalutamide H Leuva, K Sigel, M Zhou, J Wilkerson, DH Aggen, YHA Park, ... Seminars in Oncology 46 (4-5), 351-361, 2019 | 18 | 2019 |
| Influence of cancer on COVID-19 incidence, outcomes, and vaccine effectiveness: A prospective cohort study of US Veterans H Leuva, M Zhou, N Brau, ST Brown, P Mundi, TCM Rosenberg, C Luhrs, ... Seminars in Oncology 49 (5), 363-370, 2022 | 4 | 2022 |
| 429: rhabdomyolysis secondary to diabetic ketoacidosis D Damania, H Leuva, Z Khan, M Bachan Critical Care Medicine 46 (1), 198, 2018 | 3 | 2018 |
| Talazoparib (Tala) in patients (pts) with solid tumors with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study. G Srkalovic, M Rothe, PK Mangat, E Garrett-Mayer, ER Ahn, G Brouse, ... Journal of Clinical Oncology 41 (16_suppl), 3115-3115, 2023 | 1 | 2023 |
| Strong Predictors of Chromosomal Aberrations and Myeloid Neoplasia Following Immunosuppression Therapy for Severe Aplastic Anemia: A Retrospective Cohort Study EM Groarke, BA Patel, R Shalhoub, F Gutierrez-Rodrigues, P Desai, ... Blood 138, 601, 2021 | 1 | 2021 |
| Persistent Elevation of Plasma Thrombopoietin Levels in Severe Aplastic Anemia, Even with Hematologic Recovery X Zhao, X Feng, DM Townsley, T Winkler, R Desmond, MJ Olnes, ... Blood 126 (23), 3609, 2015 | 1 | 2015 |
| Assessment of PSA responses and changes in the rate of tumor growth (g-rate) with immune checkpoint inhibitors in US Veterans with prostate cancer H Leuva, G Moran, N Jammaleddine, M Maseeha, M Zhou, Y Im, ... Seminars in Oncology, 2024 | | 2024 |
| Comparing the efficacy of abiraterone and enzalutamide in United States veterans with metastatic castration-sensitive prostate cancer (mCSPC) by estimating rates of tumor … H Leuva, M Zhou, R Stamatov, BA Teply, TCM Rosenberg, CA Luhrs, ... Journal of Clinical Oncology 41 (16_suppl), 5076-5076, 2023 | | 2023 |
| An analysis to inform the timing of docetaxel use leveraging data from the United States Veterans Administration on patients with metastatic castration-sensitive prostate … M Zhou, H Leuva, R Stamatov, PS Mundi, YHA Park, SE Bates, I Faiena, ... Journal of Clinical Oncology 41 (16_suppl), 5085-5085, 2023 | | 2023 |
| Triple negative breast cancer presentation in Afro-Caribbean women in New York City. AM Ventura, E Taiwo, H Leuva, E Chiu Journal of Clinical Oncology 40 (16_suppl), e18726-e18726, 2022 | | 2022 |
| The rate of tumor growth, g, as a biomarker for overall survival (OS) in prostate cancer (PC) in clinical trials as well as in real-world data from the Veterans Administration … H Leuva, M Zhou, J Wilkerson, K Sigel, TC Hsu, DH Aggen, E Langhoff, ... Journal of Clinical Oncology 37 (15_suppl), 5074-5074, 2019 | | 2019 |
| A novel approach to mine the Veterans Administration Informatics and Computing Infrastructure (VINCI) allows one to assess the efficacy of cancer therapies: Abiraterone and … H Leuva, K Sigel, J Wilkerson, YHA Park, G McWillimas, CB Anderson, ... Journal of Clinical Oncology 36 (15_suppl), 6586-6586, 2018 | | 2018 |
| Massive Chyloperitoneum In A 74-Year-Old Male After Abdominal Aortic Aneurysm Repair H Leuva, Z Khan, M Bachan C52. CRITICAL CARE CASE REPORTS: UNUSUAL GI CAUSES OF CRITICAL ILLNESS …, 2017 | | 2017 |
| Intractable Hiccups-What Else Can We Do? D Damania, M Nandigam, H Leuva, K Singh, R Siegel, Z Khan, M Bachan A80-B. CASE REPORTS IN SLEEP MEDICINE, A2602-A2602, 2017 | | 2017 |
| C52 CRITICAL CARE CASE REPORTS: UNUSUAL GI CAUSES OF CRITICAL ILLNESS: Massive Chyloperitoneum In A 74-Year-Old Male After Abdominal Aortic Aneurysm Repair H Leuva, Z Khan, M Bachan American Journal of Respiratory and Critical Care Medicine 195, 2017 | | 2017 |
Neal YoungNIHVerified email at mail.nih.gov
